Investment ThemesDetailed Quotes
Weight Loss Drugs Watchlist

GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.

  • 1549.459
  • -18.709-1.19%
Close Mar 11 16:00 ET
1567.596High1531.536Low
Constituent Stocks: 7Top Rising: GPCR+1.84%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
GPCRStructure Therapeutics
20.5300.370+1.84%628.10K12.59M20.02020.16020.60019.3901.18B1.05B57.34M51.29M-8.71%-2.66%-15.48%-40.83%-48.68%-41.53%-24.30%--1.23%LossLoss6.00%Biotechnology
LLYEli Lilly and Co
824.060-5.700-0.69%3.77M3.11B827.200829.760832.350811.640781.20B779.43B947.99M945.84M-9.55%-8.62%-4.99%+3.24%-10.47%+12.95%+6.93%0.63%0.40%70.3770.372.50%Drug Manufacturers - General
NVONovo-Nordisk A/S
78.110-0.840-1.06%7.43M578.82M78.88078.95079.27077.000346.86B249.16B4.44B3.19B-10.73%-14.12%-6.91%-28.46%-42.94%-39.83%-9.20%1.76%0.23%23.7623.762.88%Drug Manufacturers - General
PFEPfizer
25.990-0.650-2.44%44.82M1.17B26.57026.64026.62025.870147.29B147.07B5.67B5.66B+0.93%-2.80%+0.46%+3.32%-10.77%-2.65%-0.42%6.46%0.79%18.4318.432.82%Drug Manufacturers - General
AMGNAmgen
318.890-8.470-2.59%3.08M988.01M328.800327.360329.100318.415171.31B170.89B537.20M535.88M+2.15%+1.03%+9.05%+16.58%-3.35%+19.34%+23.34%2.82%0.58%42.1842.183.26%Drug Manufacturers - General
ALTAltimmune
5.260-0.195-3.57%3.24M17.08M5.3805.4555.4505.150405.09M401.58M77.01M76.35M-11.74%-11.00%-20.42%-41.62%-30.61%-46.71%-27.05%--4.24%LossLoss5.50%Biotechnology
VKTXViking Therapeutics
26.520-1.440-5.15%7.55M193.74M26.26227.96026.81024.4402.98B2.91B112.25M109.77M-5.59%-6.36%-12.10%-44.58%-60.48%-58.20%-34.10%--6.87%LossLoss8.48%Biotechnology

News

Comments

Read more